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Summary
We report a case of an 18-year-old woman, with 
bilateral acute inflammatory pain on the hip area, during 
the premenstrual period, and progressive increase in 
volume and rigidity of both hips. Bilateral exuberant soft 
tissue calcifications were present on the radiographic 
exams, and the patient also presented with bilateral 
short-length hallux valgus. A heterozygous mutation in 
the protein kinase domain of ACVR1 gene was found, 
allowing the diagnosis of fibrodysplasia ossificans 
progressive. Due to the relation between the disease 
flares and the premenstrual period, the patient was put 
into a chemically induced amenorrhea, with no new 
inflammatory crises since.
This case illustrates the importance of an accurate 
diagnosis to prevent unnecessary diagnostic procedures, 
as well as the need to develop specific treatment 
strategies to address each patient's particular needs.
Background
Fibrodysplasia ossificans progressiva (FOP) is a rare 
and incapacitating autosomal-dominant disease 
affecting connective tissue by defectively inducing 
endochondral osteogenesis.1 Classical signs of this 
condition are hallux or thumb deformities and 
progressively debilitating heterotopic ossification, 
with normal bone formation in extraskeletal sites, 
such as soft tissues around the neck and shoulders.2 
Confusion with tumours is common, which may 
lead to aggressive and invasive diagnostic or excision 
techniques that will only accelerate the rate of bone 
growth.3
Atypical forms of FOP have also been described. 
These forms may present in two ways: classical 
FOP features in addition to one or more atypical 
features; or major variations of the two classically 
defining features.4
Managing this condition may be a challenge, and 
care must be taken to identify any trigger events 
that lead to soft tissue bone formation to develop a 
specific preventive strategy for each patient.
caSe preSentation
We present an 18-year-old young woman, born 
from an incestuous relation, with prior history 
of oligophrenia, alopecia and bilateral hearing 
impairment. Patient was otherwise healthy until 
her menarche when she began experiencing acute 
inflammatory pain on the hip area during the 
premenstrual period, with progressive increase in 
volume and rigidity of both hips.
She presented with a waddling gait, limited and 
painful mobility of both hips (0-0-75°) with hard 
and prominent bilateral masses (figure 1). There 
were no records of any traumatic events.
inveStigationS
Plain pelvic radiography (figure 2) and CT scan 
(figure 3) showed exuberant soft tissues calcifica-
tions, enveloping both hips and thighs. There was 
no involvement of the surrounding skeleton, and no 
other anomalous tissue was found on the calcifica-
tions location.
Patient was otherwise fit, with no recent history of 
weight loss, fever or other systemic signs of illness.
Due to these complaints, patient was referred to the 
orthopaedics consult for evaluation and to schedule 
a biopsy, as her family’s physician suspected of a 
neoplastic lesion. However, due to the characteristics 
of the patient’s feet (short hallux valgus with malfor-
mation of the first metatarsal) and of the anomalous 
masses, we considered there was a higher probability 
of FOP than of a malignant tumour.
Decision was made to send the patient for a 
genetics appointment, where a heterozygous muta-
tion in the protein kinase domain of ACVR1 gene, 
identified as the genetic cause of FOP, was found.
differential diagnoSiS
treatment
Due to the uncommon onset of these painful crises 
and a narrow correlation between the complaints 
and the premenstrual period, the case was discussed 
with the gynaecology department. Consider-
ation was given to muscular endometriosis being 
the possible cause for the localised heterotopic 
endochondral bone formation. Unfortunately, no 
evidence was found supporting that theory, prob-
ably due to heterotopic bone formation preventing 
visualisation of any other anomalous tissues.
Given the contraindication for any invasive 
procedure, decision was made to chemically induce 
amenorrhea to control the inflammatory crises. 
Other usual measures for FOP were also taken, 
namely caretaker education for prevention of falls 
and other traumatisms, as well as usage of cortico-
steroids during a short time period and non-steroid 
anti-inflammatory drugs whenever pain occurred.
outcome and follow-up
At 3 years’ follow-up, no new painful crises have 
been reported, with the exception of two isolated 
traumatic events.
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figure 1 Anterior and posterior aspect of the patient’s pelvis, at 
physical examination, with prominent bilateral masses in the hip area.
figure 2 Plain pelvic radiography, showing bilateral calcified masses, 
around both hips.
figure 3 Axial images of CT scan, showing evidence of heterotopic 
soft tissue calcification, without any involvement of the surrounding 




FOP is a debilitating condition that usually displays its first 
symptoms by the first decade of life, with sporadic episodes of 
painful soft tissues swelling, usually triggered by trauma, muscle 
fatigue or influenza-like illnesses, promptly followed by bone 
formation.5
With a prevalence of one case in every two million people, 
this rare disease usually occurs as a new mutation in the protein 
kinase domain of ACVR1 gene, leading to deregulation of specific 
bone morphogenetic proteins and destabilising connective tissue 
progenitor cells.6 7
FOP is often misdiagnosed by the untrained physician, and 
confused with conditions such as soft tissue sarcomas, even when 
classical clinical features are present. Aggressive and unnecessary 
diagnostic methods, such as biopsies, are commonly performed 
in these situations, leading not only to patient discomfort but 
also to an increase in local disease progression. Therefore, most 
authors advise against performing any surgical or invasive proce-
dure in these patients.8
Identification of atypical forms of FOP, as the one depicted 
on this report, has important diagnostic and therapeutic impli-
cations. Kaplan et al4 published a series of 12 atypical cases, 
some of which with a late onset, development of sparse thin hair 
and cognitive impairment. Although the inflammatory cascade 
plays a critical role in FOP,9 our research retrieved no report of 
heterotopic ossification triggered by the inflammatory crises that 
may usually occur in the premenstrual period.
This case was a therapeutic challenge since there was no trau-
matic cause related to the disease flares that could be prevented. 
Nevertheless, a multidisciplinary approach was essential to come 
up with a definitive diagnosis and a therapeutic solution that 
provided successful control of the premenstrual inflammatory 
crises.
learning points
 ► Fibrodysplasia ossificans progressiva (FOP) is a debilitating 
condition that presents with endochondral osteogenesis of 
the soft tissues, usually following trauma or other conditions 
that trigger an inflammatory response.
 ► Biopsy of FOP lesions or other invasive procedures must be 
avoided at all costs, as they will lead to worsening of this 
disease.
 ► It is possible to partially control FOP with a strategy that 
addresses the specific trigger for the inflammatory response 
that leads to bone formation.
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